Janssen Needn't Show Earnings In Off-Label Use Suit

Drugmaker Janssen Products LP doesn't have to turn over documents that show the profits it made by allegedly selling HIV/AIDS medication for off-label uses in violation of federal law, a New...

Already a subscriber? Click here to view full article